Kazuyoshi Saito

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

Kazuyoshi Saito, Daisuke Kawabata, Shingo Nakayamada et al. · Annals of the Rheumatic Diseases · 2006 · 345 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

Yoshiya Tanaka, Tsutomu Takeuchi, Tsuneyo Mimori et al. · Annals of the Rheumatic Diseases · 2010 · 280 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells

Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo et al. · Arthritis & Rheumatism · 2011 · 231 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo et al. · Annals of the Rheumatic Diseases · 2013 · 199 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +17

The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction.

F Shirakawa, Kazuyoshi Saito, Christopher A. Bonagura et al. · Molecular and Cellular Biology · 1993 · 178 citations · Full text

Life Sciences, Immunology, Molecular Biology +17